BioStock: Saniona-backed Cephagenix secures 9 MEUR in seed financing

other

▤ Summary

Saniona has announced that Cephagenix, a joint venture with Professor Jes Olesen at the University of Copenhagen, has successfully raised up to 9 MEUR in tranched seed financing. The funding round was led by AdBio Partners and AbbVie Ventures and aims to accelerate the development of Cephagenixs vascular KATP channel inhibitor program, targeting novel anti-migraine therapies. BioStock reached out to Sanionas CEO Thomas Feldthus for a comment.Read the interview with Thomas Feldthus at biostock.se:This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies